341 related articles for article (PubMed ID: 15791439)
1. Differences in [99mTc]TRODAT-1 SPECT binding to dopamine transporters in patients with multiple system atrophy and Parkinson's disease.
Swanson RL; Newberg AB; Acton PD; Siderowf A; Wintering N; Alavi A; Mozley PD; Plossl K; Udeshi M; Hurtig H
Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):302-7. PubMed ID: 15791439
[TBL] [Abstract][Full Text] [Related]
2. 99mTc-TRODAT-1 imaging of multiple system atrophy.
Lu CS; Weng YH; Chen MC; Chen RS; Tzen KY; Wey SP; Ting G; Chang HC; Yen TC
J Nucl Med; 2004 Jan; 45(1):49-55. PubMed ID: 14734673
[TBL] [Abstract][Full Text] [Related]
3. Investigating the role of 99mTc-TRODAT-1 SPECT imaging in idiopathic Parkinson's disease.
Geng Y; Shi GH; Jiang Y; Xu LX; Hu XY; Shao YQ
J Zhejiang Univ Sci B; 2005 Jan; 6(1):22-7. PubMed ID: 15593387
[TBL] [Abstract][Full Text] [Related]
4. Imaging of dopamine transporters and D2 receptors in patients with Parkinson's disease and multiple system atrophy.
Knudsen GM; Karlsborg M; Thomsen G; Krabbe K; Regeur L; Nygaard T; Videbaek C; Werdelin L
Eur J Nucl Med Mol Imaging; 2004 Dec; 31(12):1631-8. PubMed ID: 15583914
[TBL] [Abstract][Full Text] [Related]
5. Binding of [99mTc]TRODAT-1 to dopamine transporters in patients with Parkinson's disease and in healthy volunteers.
Mozley PD; Schneider JS; Acton PD; Plössl K; Stern MB; Siderowf A; Leopold NA; Li PY; Alavi A; Kung HF
J Nucl Med; 2000 Apr; 41(4):584-9. PubMed ID: 10768556
[TBL] [Abstract][Full Text] [Related]
6. [[123I]beta-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson's disease and multiple system atrophy.
Berding G; Brücke T; Odin P; Brooks DJ; Kolbe H; Gielow P; Harke H; Knoop BO; Dengler R; Knapp WH
Nuklearmedizin; 2003 Feb; 42(1):31-8. PubMed ID: 12601452
[TBL] [Abstract][Full Text] [Related]
7. Reproducibility of 99mTc-TRODAT-1 SPECT measurement of dopamine transporters in Parkinson's disease.
Hwang WJ; Yao WJ; Wey SP; Ting G
J Nucl Med; 2004 Feb; 45(2):207-13. PubMed ID: 14960637
[TBL] [Abstract][Full Text] [Related]
8. Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease.
Weintraub D; Newberg AB; Cary MS; Siderowf AD; Moberg PJ; Kleiner-Fisman G; Duda JE; Stern MB; Mozley D; Katz IR
J Nucl Med; 2005 Feb; 46(2):227-32. PubMed ID: 15695780
[TBL] [Abstract][Full Text] [Related]
9. Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease.
Scherfler C; Seppi K; Donnemiller E; Goebel G; Brenneis C; Virgolini I; Wenning GK; Poewe W
Brain; 2005 Jul; 128(Pt 7):1605-12. PubMed ID: 15817519
[TBL] [Abstract][Full Text] [Related]
10. Dopamine transporter SPECT using fast kinetic ligands: 123I-FP-beta-CIT versus 99mTc-TRODAT-1.
Van Laere K; De Ceuninck L; Dom R; Van den Eynden J; Vanbilloen H; Cleynhens J; Dupont P; Bormans G; Verbruggen A; Mortelmans L
Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1119-27. PubMed ID: 15064872
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity and specificity of 99mTc-TRODAT-1 SPECT imaging in differentiating patients with idiopathic Parkinson's disease from healthy subjects.
Weng YH; Yen TC; Chen MC; Kao PF; Tzen KY; Chen RS; Wey SP; Ting G; Lu CS
J Nucl Med; 2004 Mar; 45(3):393-401. PubMed ID: 15001678
[TBL] [Abstract][Full Text] [Related]
12. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy.
Oh M; Kim JS; Kim JY; Shin KH; Park SH; Kim HO; Moon DH; Oh SJ; Chung SJ; Lee CS
J Nucl Med; 2012 Mar; 53(3):399-406. PubMed ID: 22323779
[TBL] [Abstract][Full Text] [Related]
13. Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP.
Kim YJ; Ichise M; Ballinger JR; Vines D; Erami SS; Tatschida T; Lang AE
Mov Disord; 2002 Mar; 17(2):303-12. PubMed ID: 11921116
[TBL] [Abstract][Full Text] [Related]
14. [Imaging of dopamine transporter with Tc99m-Trodat-SPECT in movement disorders].
Kanyó B; Argyelán M; Dibó G; Szakonyi Z; Vécsei L; Fülöp F; Láncz A; Forgács P; Pávics L
Ideggyogy Sz; 2003 Jul; 56(7-8):231-40. PubMed ID: 12971118
[TBL] [Abstract][Full Text] [Related]
15. The optimal imaging time for [99Tcm]TRODAT-1/SPET in normal subjects and patients with Parkinson's disease.
Kao PF; Tzen KY; Yen TC; Lu CS; Weng YH; Wey SP; Ting G
Nucl Med Commun; 2001 Feb; 22(2):151-4. PubMed ID: 11258401
[TBL] [Abstract][Full Text] [Related]
16. [(123)I]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy.
Varrone A; Marek KL; Jennings D; Innis RB; Seibyl JP
Mov Disord; 2001 Nov; 16(6):1023-32. PubMed ID: 11748733
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution and dosimetry of TRODAT-1: a technetium-99m tropane for imaging dopamine transporters.
Mozley PD; Stubbs JB; Plössl K; Dresel SH; Barraclough ED; Alavi A; Araujo LI; Kung HF
J Nucl Med; 1998 Dec; 39(12):2069-76. PubMed ID: 9867143
[TBL] [Abstract][Full Text] [Related]
18. 123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Antonini A; Benti R; De Notaris R; Tesei S; Zecchinelli A; Sacilotto G; Meucci N; Canesi M; Mariani C; Pezzoli G; Gerundini P
Neurol Sci; 2003 Oct; 24(3):149-50. PubMed ID: 14598060
[TBL] [Abstract][Full Text] [Related]
19. Quantification of Parkinson's disease-related network expression with ECD SPECT.
Eckert T; Van Laere K; Tang C; Lewis DE; Edwards C; Santens P; Eidelberg D
Eur J Nucl Med Mol Imaging; 2007 Apr; 34(4):496-501. PubMed ID: 17096095
[TBL] [Abstract][Full Text] [Related]
20. Single photon emission computer tomography of dopamine transporters in monkeys and humans with 99mTc-TRODAT-1.
Hu P; Chen L; Zhang HQ; Li JR; Liang H
Chin Med J (Engl); 2004 Jul; 117(7):1056-9. PubMed ID: 15265382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
